Cargando…
Immunoregulatory effects of RGMb in gut inflammation
Graft-versus-host disease (GvHD) is a major complication after allogeneic hematopoietic cell transplantation (HCT). Current strategies to prevent GvHD with immunosuppressive drugs carry significant morbidity and may affect the graft-versus-tumor (GVT) effect. Inflammatory bowel disease (IBD) is an i...
Autores principales: | Pérez-Cruz, Magdiel, Iliopoulou, Bettina P., Hsu, Katie, Wu, Hsin-Hsu, Erkers, Tom, Swaminathan, Kavya, Tang, Sai-Wen, Bader, Cameron S., Kambham, Neeraja, Xie, Bryan, Dekruyff, Rosemarie H., Freeman, Gordon J., Meyer, Everett |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676481/ https://www.ncbi.nlm.nih.gov/pubmed/36420263 http://dx.doi.org/10.3389/fimmu.2022.960329 |
Ejemplares similares
-
RGMb is a novel binding partner for PD-L2 and its engagement with PD-L2 promotes respiratory tolerance
por: Xiao, Yanping, et al.
Publicado: (2014) -
Dragon (RGMb) induces oxaliplatin resistance in colon cancer cells
por: Shi, Ying, et al.
Publicado: (2016) -
RGMB enhances the suppressive activity of the monomeric secreted form of CTLA-4
por: Sekiya, Takashi, et al.
Publicado: (2019) -
Microbiota-associated immunotherapy resistance caused by deficient PD-L2 - RGMb signaling
por: Fidelle, Marine, et al.
Publicado: (2023) -
RGMB-AS1/miR-4428/PBX1 axis drives the progression of cervical cancer
por: Shen, Chenge, et al.
Publicado: (2020)